Similar to recombinant virus vector vaccines, nucleic acid vaccines (including DNA vaccines and mRNA vaccines) can directly produce pathogen antigen proteins in the human body, which is an emerging vaccine technology. Creative Biostructure is accumulating preclinical research experience in nucleic acid vaccines, hoping to provide the optimal vaccine development services for different types of diseases caused by coronaviruses.